Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Dingdang Health Technology Group's Net Margin % or its related term are showing as below:
HKSE:09886'
s Net Margin % Range Over the Past 10 Years
Min: -65.45 Med: -20.05 Max: -1
Current: -1
HKSE:09886's Net Margin % is ranked worse than 66.97% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs HKSE:09886: -1.00
Dingdang Health Technology Group (HKSE:09886) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Dingdang Health Technology Group Net Margin % Related Terms
Dingdang Health Technology Group Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group Net Margin % Chart
HKSE:09886 vs VEEV, BTSG, HQY: Net Margin % Comparison
For the Health Information Services subindustry, Dingdang Health Technology Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dingdang Health Technology Group Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group (HKSE:09886) has a Net Margin % of -2.67% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Dingdang Health Technology Group and its competitors. According to the industry distribution chart, Dingdang Health Technology Group ranks #448 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 67%.
Is Dingdang Health Technology Group's Net Margin % too high?
Dingdang Health Technology Group's current Net Margin % is -2.67%. Based on the distribution chart, Dingdang Health Technology Group ranks #448 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dingdang Health Technology Group has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dingdang Health Technology Group's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Dingdang Health Technology Group ranks #448 out of 669 companies for Net Margin %. This places Dingdang Health Technology Group in the lower half of its industry. The industry median Net Margin % is 2.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Dingdang Health Technology Group and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dingdang Health Technology Group's current Net Margin % is -2.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dingdang Health Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dingdang Health Technology Group (HKSE:09886) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$1.13, compared to a current price of HK$0.83 — trading 27% below its estimated fair value. The current Net Margin % is -2.67%. Dingdang Health Technology Group's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Dingdang Health Technology Group (HKSE:09886), the current Net Margin % is -2.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dingdang Health Technology Group (HKSE:09886) Overvalued in 2026?
Based on GuruFocus' analysis, Dingdang Health Technology Group stock appears to be undervalued.
The current stock price of HK$0.83 is trading 27% below its estimated GF Value™ of HK$1.13.
GuruFocus considers Dingdang Health Technology Group to be Modestly Undervalued.
Key valuation signals for HKSE:09886:
Net Margin %: -2.67%
GF Value™: HK$1.13 vs. price of HK$0.83 (27% below fair value)
No single metric tells the full story. See the HKSE:09886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions. All of the company's revenue is generated from the PRC.
68GF Score
Get the complete analysis for HKSE:09886
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09886 has been successfully added to your 
